James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 25,000 shares at $64.86 ($1.6M) on 2018-10-09, disclosed to the SEC on 2018-10-10.
Open-market sale of $1.6M GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.23 | 19,270 | $1.2M | 76.9% |
| 2 | $64.86 | 5,730 | $372K | 23.1% |
| Total | $64.37 avg | 25,000 | $1.6M | 100% |
| Filing → |
| GHDX | SELL | 2019-09-11 | $311K | — | Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-08-12 | $273K | — | Filing → |